|
2022
|
P/S
|
Research and development of pharmaceutical preparations; product research and development for oth... |
|
|
P/S
|
Pharmaceutical preparations used for the treatment of
cancer; and pharmaceutical preparations us... |
|
2021
|
Invention
|
Methods of treating viral infection. Provided herein are methods of preventing and treating viral... |
|
|
Invention
|
Oxygen linked pyrimidine derivatives.
The present invention relates to pyrimidine compounds that... |
|
2020
|
Invention
|
Methods of treating transplant rejection.
The present invention provides the use of protein kina... |
|
2019
|
Invention
|
Oxygen linked pyrimidine derivatives. The present invention relates to pyrimidine compounds that ... |
|
|
Invention
|
Methods of treating flt3-mutated hematologic cancers.
Methods to inhibit FLT3 activity in a subj... |
|
2016
|
Invention
|
Methods of treating transplant rejection. The present invention provides the use of protein kinas... |
|
2015
|
Invention
|
Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activit... |
|
|
Invention
|
11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptaco... |
|
|
P/S
|
Pharmaceutical preparations and products. Education services and providing course materials in co... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherap... |
|
2014
|
P/S
|
Research, development, engineering, testing, product evaluation, and inspection in the field of p... |
|
|
P/S
|
Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products an... |
|
2012
|
P/S
|
Pharmaceutical products. Providing online publications in the nature of newsletters, brochures, r... |
|
2011
|
P/S
|
Medical and scientific research, namely conducting clinical trials for pharmaceutical preparation... |
|
2010
|
Invention
|
(9e)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,1... |
|
2009
|
Invention
|
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacos... |
|
2002
|
P/S
|
Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations use... |
|
1998
|
P/S
|
Pharmaceutical preparations, namely, cell signaling pathway modulators of a non-living nature, fo... |
|
1997
|
P/S
|
Pharmaceutical products. Synthesis of non-living compounds that are useful as therapeutic agents ... |
|
1993
|
P/S
|
pharmaceutical preparations, namely cell signaling pathway modulators of a non-living nature, for... |
